

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 5.02104962 |
| 2 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 4.53854066 |
| 3 | protein retention in ER lumen (GO:0006621) | 4.21730865 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.94996661 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.90737141 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 3.90737141 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.86609385 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 3.86609385 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 3.78647748 |
| 10 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.76098466 |
| 11 | sulfur amino acid catabolic process (GO:0000098) | 3.59019563 |
| 12 | synaptic vesicle maturation (GO:0016188) | 3.57658960 |
| 13 | layer formation in cerebral cortex (GO:0021819) | 3.54330521 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.53282160 |
| 15 | cochlea morphogenesis (GO:0090103) | 3.49332969 |
| 16 | convergent extension (GO:0060026) | 3.47506365 |
| 17 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 3.44703081 |
| 18 | regulation of cholesterol homeostasis (GO:2000188) | 3.40408181 |
| 19 | lysine metabolic process (GO:0006553) | 3.34023652 |
| 20 | lysine catabolic process (GO:0006554) | 3.34023652 |
| 21 | locomotory exploration behavior (GO:0035641) | 3.33416009 |
| 22 | cellular modified amino acid catabolic process (GO:0042219) | 3.31088762 |
| 23 | cell-cell junction maintenance (GO:0045217) | 3.30450845 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 3.28722155 |
| 25 | glyoxylate metabolic process (GO:0046487) | 3.27753060 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 3.26849058 |
| 27 | nucleobase catabolic process (GO:0046113) | 3.23023406 |
| 28 | semaphorin-plexin signaling pathway (GO:0071526) | 3.22657352 |
| 29 | regulation of establishment of planar polarity (GO:0090175) | 3.22176530 |
| 30 | kynurenine metabolic process (GO:0070189) | 3.21831049 |
| 31 | basement membrane organization (GO:0071711) | 3.17009657 |
| 32 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.12569182 |
| 33 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.08703199 |
| 34 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.08179574 |
| 35 | regulation of early endosome to late endosome transport (GO:2000641) | 3.07705108 |
| 36 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.04825973 |
| 37 | bile acid biosynthetic process (GO:0006699) | 3.04252673 |
| 38 | paraxial mesoderm development (GO:0048339) | 3.02388654 |
| 39 | adherens junction assembly (GO:0034333) | 2.99560744 |
| 40 | negative regulation of sterol transport (GO:0032372) | 2.97034006 |
| 41 | negative regulation of cholesterol transport (GO:0032375) | 2.97034006 |
| 42 | glutamate metabolic process (GO:0006536) | 2.96811887 |
| 43 | urea cycle (GO:0000050) | 2.96461027 |
| 44 | urea metabolic process (GO:0019627) | 2.96461027 |
| 45 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.94819133 |
| 46 | cysteine metabolic process (GO:0006534) | 2.92387788 |
| 47 | cellular ketone body metabolic process (GO:0046950) | 2.92365496 |
| 48 | high-density lipoprotein particle remodeling (GO:0034375) | 2.90711409 |
| 49 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.84973954 |
| 50 | protein carboxylation (GO:0018214) | 2.84973954 |
| 51 | endothelial cell chemotaxis (GO:0035767) | 2.84554569 |
| 52 | skeletal muscle organ development (GO:0060538) | 2.84389448 |
| 53 | camera-type eye morphogenesis (GO:0048593) | 2.82985918 |
| 54 | Golgi transport vesicle coating (GO:0048200) | 2.81527550 |
| 55 | COPI coating of Golgi vesicle (GO:0048205) | 2.81527550 |
| 56 | regulation of fibrinolysis (GO:0051917) | 2.79877285 |
| 57 | indole-containing compound catabolic process (GO:0042436) | 2.79029059 |
| 58 | indolalkylamine catabolic process (GO:0046218) | 2.79029059 |
| 59 | tryptophan catabolic process (GO:0006569) | 2.79029059 |
| 60 | coenzyme catabolic process (GO:0009109) | 2.77654488 |
| 61 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.77023660 |
| 62 | postsynaptic membrane organization (GO:0001941) | 2.72592462 |
| 63 | heterochromatin organization (GO:0070828) | 2.72350569 |
| 64 | axon extension involved in axon guidance (GO:0048846) | 2.70908765 |
| 65 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.70908765 |
| 66 | cerebellar granule cell differentiation (GO:0021707) | 2.70722729 |
| 67 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.69140961 |
| 68 | positive regulation of lipid catabolic process (GO:0050996) | 2.68494053 |
| 69 | alanine transport (GO:0032328) | 2.68094488 |
| 70 | axon extension (GO:0048675) | 2.67791080 |
| 71 | nucleosome disassembly (GO:0006337) | 2.67596829 |
| 72 | protein-DNA complex disassembly (GO:0032986) | 2.67596829 |
| 73 | negative regulation of cell size (GO:0045792) | 2.67506414 |
| 74 | non-canonical Wnt signaling pathway (GO:0035567) | 2.67398649 |
| 75 | cell migration in hindbrain (GO:0021535) | 2.67361591 |
| 76 | cerebellar Purkinje cell layer development (GO:0021680) | 2.63807166 |
| 77 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.63499984 |
| 78 | serine family amino acid catabolic process (GO:0009071) | 2.63451653 |
| 79 | nitrogen cycle metabolic process (GO:0071941) | 2.63414096 |
| 80 | complement activation, alternative pathway (GO:0006957) | 2.63151403 |
| 81 | drug catabolic process (GO:0042737) | 2.60750243 |
| 82 | protein heterotrimerization (GO:0070208) | 2.60748920 |
| 83 | maternal placenta development (GO:0001893) | 2.59121583 |
| 84 | epoxygenase P450 pathway (GO:0019373) | 2.57445563 |
| 85 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.56839497 |
| 86 | reverse cholesterol transport (GO:0043691) | 2.56574675 |
| 87 | plasma lipoprotein particle clearance (GO:0034381) | 2.56363316 |
| 88 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.55227743 |
| 89 | bile acid metabolic process (GO:0008206) | 2.55106131 |
| 90 | neural tube development (GO:0021915) | 2.54964967 |
| 91 | glutamate secretion (GO:0014047) | 2.54738838 |
| 92 | skin morphogenesis (GO:0043589) | 2.54552229 |
| 93 | proline transport (GO:0015824) | 2.53778531 |
| 94 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.53682754 |
| 95 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.53575314 |
| 96 | apical protein localization (GO:0045176) | 2.53061066 |
| 97 | eye morphogenesis (GO:0048592) | 2.52910610 |
| 98 | cell-substrate adherens junction assembly (GO:0007045) | 2.52587264 |
| 99 | focal adhesion assembly (GO:0048041) | 2.52587264 |
| 100 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.52548766 |
| 101 | tryptophan metabolic process (GO:0006568) | 2.52340902 |
| 102 | cellular response to prostaglandin stimulus (GO:0071379) | 2.51996906 |
| 103 | vocalization behavior (GO:0071625) | 2.51777036 |
| 104 | notochord development (GO:0030903) | 2.50581676 |
| 105 | positive regulation of fatty acid oxidation (GO:0046321) | 2.50412492 |
| 106 | positive regulation of synapse maturation (GO:0090129) | 2.49650640 |
| 107 | alpha-amino acid catabolic process (GO:1901606) | 2.49121707 |
| 108 | cell communication by electrical coupling (GO:0010644) | 2.48972714 |
| 109 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.48399964 |
| 110 | homocysteine metabolic process (GO:0050667) | 2.48194678 |
| 111 | regulation of protein activation cascade (GO:2000257) | 2.47863709 |
| 112 | arginine metabolic process (GO:0006525) | 2.47824320 |
| 113 | barbed-end actin filament capping (GO:0051016) | 2.47449918 |
| 114 | sodium ion export (GO:0071436) | 2.47358109 |
| 115 | regulation of synapse structural plasticity (GO:0051823) | 2.47173688 |
| 116 | ketone body metabolic process (GO:1902224) | 2.47082556 |
| 117 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.46764152 |
| 118 | cellular amino acid catabolic process (GO:0009063) | 2.46507657 |
| 119 | dendritic spine morphogenesis (GO:0060997) | 2.45770092 |
| 120 | aspartate family amino acid catabolic process (GO:0009068) | 2.44473598 |
| 121 | negative regulation of microtubule polymerization (GO:0031115) | 2.43566546 |
| 122 | cell junction maintenance (GO:0034331) | 2.42706864 |
| 123 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.42702528 |
| 124 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.41531475 |
| 125 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.41410868 |
| 126 | regulation of triglyceride catabolic process (GO:0010896) | 2.41054881 |
| 127 | exogenous drug catabolic process (GO:0042738) | 2.41019163 |
| 128 | protein targeting to plasma membrane (GO:0072661) | 2.40638005 |
| 129 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.40102367 |
| 130 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.40102367 |
| 131 | triglyceride homeostasis (GO:0070328) | 2.40039908 |
| 132 | acylglycerol homeostasis (GO:0055090) | 2.40039908 |
| 133 | establishment of apical/basal cell polarity (GO:0035089) | 2.39679116 |
| 134 | activation of protein kinase A activity (GO:0034199) | 2.39167779 |
| 135 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.38552527 |
| 136 | amino-acid betaine metabolic process (GO:0006577) | 2.38166886 |
| 137 | regulation of cholesterol esterification (GO:0010872) | 2.37500211 |
| 138 | acetyl-CoA metabolic process (GO:0006084) | 2.37246581 |
| 139 | kidney mesenchyme development (GO:0072074) | 2.37206404 |
| 140 | protein-lipid complex remodeling (GO:0034368) | 2.36764246 |
| 141 | macromolecular complex remodeling (GO:0034367) | 2.36764246 |
| 142 | plasma lipoprotein particle remodeling (GO:0034369) | 2.36764246 |
| 143 | negative regulation of catenin import into nucleus (GO:0035414) | 2.36426141 |
| 144 | dendrite morphogenesis (GO:0048813) | 2.36230175 |
| 145 | diaphragm development (GO:0060539) | 2.35629797 |
| 146 | mating behavior (GO:0007617) | 2.35351280 |
| 147 | phosphate ion transport (GO:0006817) | 2.35135302 |
| 148 | neuron projection extension (GO:1990138) | 2.34975161 |
| 149 | cranial nerve morphogenesis (GO:0021602) | 2.34935901 |
| 150 | positive regulation of axon extension (GO:0045773) | 2.34399558 |
| 151 | neuromuscular process controlling balance (GO:0050885) | 2.33916612 |
| 152 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.33853120 |
| 153 | regulation of fatty acid oxidation (GO:0046320) | 2.32909450 |
| 154 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.32791532 |
| 155 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.32683956 |
| 156 | regulation of complement activation (GO:0030449) | 2.32363728 |
| 157 | lens fiber cell development (GO:0070307) | 2.31089709 |
| 158 | 2-oxoglutarate metabolic process (GO:0006103) | 2.31002798 |
| 159 | midgut development (GO:0007494) | 2.30845609 |
| 160 | myelination in peripheral nervous system (GO:0022011) | 2.29560854 |
| 161 | peripheral nervous system axon ensheathment (GO:0032292) | 2.29560854 |
| 162 | negative regulation of fatty acid transport (GO:2000192) | 2.28813320 |
| 163 | negative regulation of lipid transport (GO:0032369) | 2.28731528 |
| 164 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.28603536 |
| 165 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.28459112 |
| 166 | epithelial cell-cell adhesion (GO:0090136) | 2.27216426 |
| 167 | collagen fibril organization (GO:0030199) | 2.26001865 |
| 168 | neuron recognition (GO:0008038) | 2.24893200 |
| 169 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.24837788 |
| 170 | cellular potassium ion homeostasis (GO:0030007) | 2.24487703 |
| 171 | outer ear morphogenesis (GO:0042473) | 2.22913923 |
| 172 | RNA localization (GO:0006403) | 2.22172221 |
| 173 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.21533368 |
| 174 | proline biosynthetic process (GO:0006561) | 2.20265735 |
| 175 | dopamine receptor signaling pathway (GO:0007212) | 2.19259903 |
| 176 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.18563954 |
| 177 | axonal fasciculation (GO:0007413) | 2.18057452 |
| 178 | apoptotic process involved in morphogenesis (GO:0060561) | 2.17261997 |
| 179 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.16459899 |
| 180 | developmental cell growth (GO:0048588) | 2.14465792 |
| 181 | protein localization to endosome (GO:0036010) | 2.13429669 |
| 182 | negative regulation of embryonic development (GO:0045992) | 2.13131004 |
| 183 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.12668032 |
| 184 | regulation of catenin import into nucleus (GO:0035412) | 2.11313800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.25310898 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.18213852 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.88759364 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.76291513 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.52809647 |
| 6 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.47762077 |
| 7 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.21778375 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.16104415 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.09834322 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.07563856 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.07187017 |
| 12 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.02472796 |
| 13 | KDM2B_26808549_Chip-Seq_K562_Human | 1.99834960 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.90414494 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.88602732 |
| 16 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.84043690 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.81318211 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.81318211 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.80893304 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.74308055 |
| 21 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.70073111 |
| 22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67576493 |
| 23 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.66036901 |
| 24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.65278944 |
| 25 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.65101489 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64955343 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.64219900 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63499206 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.62035151 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.58939896 |
| 31 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.57992191 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.57977084 |
| 33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.57887048 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.57289324 |
| 35 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.56183156 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.56181308 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.55593406 |
| 38 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.52573466 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.52184802 |
| 40 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.51658592 |
| 41 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.51563859 |
| 42 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.50768133 |
| 43 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.49575244 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.49317336 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.48649255 |
| 46 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.48294902 |
| 47 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47325368 |
| 48 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.45825690 |
| 49 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.43715186 |
| 50 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.43244027 |
| 51 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.42528532 |
| 52 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.41898165 |
| 53 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.40934433 |
| 54 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38010038 |
| 55 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.37147069 |
| 56 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.35069486 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.34895934 |
| 58 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.33490554 |
| 59 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.32654341 |
| 60 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.32248575 |
| 61 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.30078790 |
| 62 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.28542376 |
| 63 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28075248 |
| 64 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.27784557 |
| 65 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27393974 |
| 66 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.26700567 |
| 67 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26518516 |
| 68 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.24872573 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24650197 |
| 70 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.24233282 |
| 71 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.23529117 |
| 72 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.22573058 |
| 73 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.22342322 |
| 74 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.21185301 |
| 75 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.20373316 |
| 76 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.19948901 |
| 77 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19465111 |
| 78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19199880 |
| 79 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19136642 |
| 80 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18813274 |
| 81 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.18287968 |
| 82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17389530 |
| 83 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.17222296 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16534893 |
| 85 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16516057 |
| 86 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16378072 |
| 87 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.15327965 |
| 88 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.14320372 |
| 89 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.13980374 |
| 90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.13959688 |
| 91 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.13564386 |
| 92 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13010306 |
| 93 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12922983 |
| 94 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.12504247 |
| 95 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12383027 |
| 96 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11130245 |
| 97 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11091411 |
| 98 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.09379083 |
| 99 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.09371078 |
| 100 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.08857957 |
| 101 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.07714081 |
| 102 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07607175 |
| 103 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07419339 |
| 104 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.07008974 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06760784 |
| 106 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03973587 |
| 107 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03943328 |
| 108 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.03450231 |
| 109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03343871 |
| 110 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.02926036 |
| 111 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02910427 |
| 112 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99384953 |
| 113 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.94546086 |
| 114 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94350352 |
| 115 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93358872 |
| 116 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92264040 |
| 117 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91956428 |
| 118 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.91807707 |
| 119 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91430351 |
| 120 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.89707447 |
| 121 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.89306113 |
| 122 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.88995639 |
| 123 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88651423 |
| 124 | * P68_20966046_ChIP-Seq_HELA_Human | 0.86621847 |
| 125 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86610108 |
| 126 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.85867095 |
| 127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.83697481 |
| 128 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83175218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.59600483 |
| 2 | MP0005360_urolithiasis | 4.40788935 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.88894453 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.61073340 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.48987119 |
| 6 | MP0005365_abnormal_bile_salt | 3.36279994 |
| 7 | MP0004858_abnormal_nervous_system | 2.79718218 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.52720351 |
| 9 | MP0003252_abnormal_bile_duct | 2.50690688 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.32844240 |
| 11 | MP0000566_synostosis | 2.14012834 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.10819155 |
| 13 | MP0009840_abnormal_foam_cell | 2.00800167 |
| 14 | MP0003283_abnormal_digestive_organ | 1.93946378 |
| 15 | MP0008961_abnormal_basal_metabolism | 1.91466349 |
| 16 | MP0005083_abnormal_biliary_tract | 1.86563312 |
| 17 | MP0005503_abnormal_tendon_morphology | 1.86065085 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 1.85448641 |
| 19 | MP0003329_amyloid_beta_deposits | 1.80081010 |
| 20 | MP0003635_abnormal_synaptic_transmissio | 1.70863037 |
| 21 | MP0002909_abnormal_adrenal_gland | 1.70815307 |
| 22 | MP0003123_paternal_imprinting | 1.69949382 |
| 23 | MP0005409_darkened_coat_color | 1.64425736 |
| 24 | MP0005332_abnormal_amino_acid | 1.62810605 |
| 25 | MP0004270_analgesia | 1.59379004 |
| 26 | MP0000049_abnormal_middle_ear | 1.57713028 |
| 27 | MP0002822_catalepsy | 1.55726524 |
| 28 | MP0010234_abnormal_vibrissa_follicle | 1.55402944 |
| 29 | MP0003385_abnormal_body_wall | 1.54158071 |
| 30 | MP0004130_abnormal_muscle_cell | 1.52230379 |
| 31 | MP0005623_abnormal_meninges_morphology | 1.48321127 |
| 32 | MP0000579_abnormal_nail_morphology | 1.45306060 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.43233929 |
| 34 | MP0002063_abnormal_learning/memory/cond | 1.42817366 |
| 35 | MP0002697_abnormal_eye_size | 1.39990661 |
| 36 | MP0009379_abnormal_foot_pigmentation | 1.39277327 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.37683866 |
| 38 | MP0001849_ear_inflammation | 1.31835289 |
| 39 | MP0004019_abnormal_vitamin_homeostasis | 1.30983107 |
| 40 | MP0005248_abnormal_Harderian_gland | 1.28692156 |
| 41 | MP0009250_abnormal_appendicular_skeleto | 1.27606604 |
| 42 | MP0003279_aneurysm | 1.27444601 |
| 43 | MP0000762_abnormal_tongue_morphology | 1.27328800 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.27321270 |
| 45 | MP0004885_abnormal_endolymph | 1.25436911 |
| 46 | MP0005508_abnormal_skeleton_morphology | 1.24253874 |
| 47 | MP0000733_abnormal_muscle_development | 1.23955159 |
| 48 | MP0000428_abnormal_craniofacial_morphol | 1.23453804 |
| 49 | MP0002116_abnormal_craniofacial_bone | 1.23214381 |
| 50 | MP0001299_abnormal_eye_distance/ | 1.22440932 |
| 51 | MP0001666_abnormal_nutrient_absorption | 1.22243579 |
| 52 | MP0003075_altered_response_to | 1.22136407 |
| 53 | MP0003122_maternal_imprinting | 1.20645824 |
| 54 | MP0008438_abnormal_cutaneous_collagen | 1.20190713 |
| 55 | MP0003861_abnormal_nervous_system | 1.18724571 |
| 56 | MP0000604_amyloidosis | 1.18157130 |
| 57 | MP0002254_reproductive_system_inflammat | 1.14974857 |
| 58 | MP0005187_abnormal_penis_morphology | 1.14970833 |
| 59 | MP0002932_abnormal_joint_morphology | 1.14282474 |
| 60 | MP0003195_calcinosis | 1.14098122 |
| 61 | MP0002653_abnormal_ependyma_morphology | 1.13615697 |
| 62 | MP0009672_abnormal_birth_weight | 1.13094924 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.10745485 |
| 64 | MP0003938_abnormal_ear_development | 1.10557607 |
| 65 | MP0009053_abnormal_anal_canal | 1.10534333 |
| 66 | MP0000609_abnormal_liver_physiology | 1.09330282 |
| 67 | MP0000462_abnormal_digestive_system | 1.08596155 |
| 68 | MP0003634_abnormal_glial_cell | 1.07960649 |
| 69 | MP0000534_abnormal_ureter_morphology | 1.07460025 |
| 70 | MP0002092_abnormal_eye_morphology | 1.06691118 |
| 71 | MP0009384_cardiac_valve_regurgitation | 1.05003716 |
| 72 | MP0001346_abnormal_lacrimal_gland | 1.04974753 |
| 73 | MP0004233_abnormal_muscle_weight | 1.04040177 |
| 74 | MP0000778_abnormal_nervous_system | 1.02821140 |
| 75 | MP0003755_abnormal_palate_morphology | 1.02701979 |
| 76 | MP0005076_abnormal_cell_differentiation | 1.02440404 |
| 77 | MP0004185_abnormal_adipocyte_glucose | 1.01189301 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 1.01161881 |
| 79 | MP0009745_abnormal_behavioral_response | 0.98404533 |
| 80 | MP0004811_abnormal_neuron_physiology | 0.95882964 |
| 81 | MP0005275_abnormal_skin_tensile | 0.95608287 |
| 82 | MP0010030_abnormal_orbit_morphology | 0.95312892 |
| 83 | MP0003935_abnormal_craniofacial_develop | 0.95040166 |
| 84 | MP0002152_abnormal_brain_morphology | 0.93924354 |
| 85 | MP0001348_abnormal_lacrimal_gland | 0.93647912 |
| 86 | MP0005666_abnormal_adipose_tissue | 0.93431463 |
| 87 | MP0002064_seizures | 0.93270220 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92749592 |
| 89 | MP0004272_abnormal_basement_membrane | 0.92722930 |
| 90 | MP0002114_abnormal_axial_skeleton | 0.92578019 |
| 91 | MP0003091_abnormal_cell_migration | 0.92407432 |
| 92 | MP0002234_abnormal_pharynx_morphology | 0.92354021 |
| 93 | MP0000537_abnormal_urethra_morphology | 0.92014126 |
| 94 | MP0000751_myopathy | 0.91960751 |
| 95 | MP0002896_abnormal_bone_mineralization | 0.90686407 |
| 96 | MP0002060_abnormal_skin_morphology | 0.90228576 |
| 97 | MP0000955_abnormal_spinal_cord | 0.89628195 |
| 98 | MP0003119_abnormal_digestive_system | 0.89267480 |
| 99 | MP0001502_abnormal_circadian_rhythm | 0.88693953 |
| 100 | MP0005058_abnormal_lysosome_morphology | 0.88195904 |
| 101 | MP0001188_hyperpigmentation | 0.87291826 |
| 102 | MP0002085_abnormal_embryonic_tissue | 0.87246801 |
| 103 | MP0000432_abnormal_head_morphology | 0.87035732 |
| 104 | MP0003011_delayed_dark_adaptation | 0.86968947 |
| 105 | MP0002081_perinatal_lethality | 0.86013763 |
| 106 | MP0002089_abnormal_postnatal_growth/wei | 0.84701259 |
| 107 | MP0002733_abnormal_thermal_nociception | 0.84688654 |
| 108 | MP0002837_dystrophic_cardiac_calcinosis | 0.82576983 |
| 109 | MP0003937_abnormal_limbs/digits/tail_de | 0.81656759 |
| 110 | MP0002233_abnormal_nose_morphology | 0.81363224 |
| 111 | MP0003303_peritoneal_inflammation | 0.80489224 |
| 112 | MP0003115_abnormal_respiratory_system | 0.79745876 |
| 113 | MP0002572_abnormal_emotion/affect_behav | 0.79534103 |
| 114 | MP0002108_abnormal_muscle_morphology | 0.78651195 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.77221358 |
| 116 | MP0005375_adipose_tissue_phenotype | 0.76989112 |
| 117 | MP0005670_abnormal_white_adipose | 0.76937876 |
| 118 | MP0003566_abnormal_cell_adhesion | 0.76355279 |
| 119 | MP0002111_abnormal_tail_morphology | 0.76179275 |
| 120 | MP0005257_abnormal_intraocular_pressure | 0.76143151 |
| 121 | MP0003806_abnormal_nucleotide_metabolis | 0.75305420 |
| 122 | MP0008874_decreased_physiological_sensi | 0.74986373 |
| 123 | MP0005197_abnormal_uvea_morphology | 0.74564485 |
| 124 | MP0002090_abnormal_vision | 0.74471826 |
| 125 | MP0001730_embryonic_growth_arrest | 0.73722711 |
| 126 | MP0001756_abnormal_urination | 0.73424188 |
| 127 | MP0003868_abnormal_feces_composition | 0.72772654 |
| 128 | MP0003942_abnormal_urinary_system | 0.72772010 |
| 129 | MP0002882_abnormal_neuron_morphology | 0.72688758 |
| 130 | MP0000467_abnormal_esophagus_morphology | 0.72602609 |
| 131 | MP0005423_abnormal_somatic_nervous | 0.72249510 |
| 132 | MP0009643_abnormal_urine_homeostasis | 0.72097171 |
| 133 | MP0002138_abnormal_hepatobiliary_system | 0.71678485 |
| 134 | MP0001958_emphysema | 0.71494078 |
| 135 | MP0005501_abnormal_skin_physiology | 0.71454696 |
| 136 | MP0002069_abnormal_eating/drinking_beha | 0.70367659 |
| 137 | MP0003633_abnormal_nervous_system | 0.70268975 |
| 138 | MP0001915_intracranial_hemorrhage | 0.69940033 |
| 139 | MP0001879_abnormal_lymphatic_vessel | 0.68795812 |
| 140 | MP0003315_abnormal_perineum_morphology | 0.67999342 |
| 141 | MP0002078_abnormal_glucose_homeostasis | 0.67865120 |
| 142 | MP0003300_gastrointestinal_ulcer | 0.67714250 |
| 143 | MP0004087_abnormal_muscle_fiber | 0.67137204 |
| 144 | MP0000681_abnormal_thyroid_gland | 0.67070704 |
| 145 | MP0002796_impaired_skin_barrier | 0.66345546 |
| 146 | MP0003879_abnormal_hair_cell | 0.65942634 |
| 147 | MP0002734_abnormal_mechanical_nocicepti | 0.65390938 |
| 148 | MP0002249_abnormal_larynx_morphology | 0.65025655 |
| 149 | MP0005535_abnormal_body_temperature | 0.64904291 |
| 150 | MP0003690_abnormal_glial_cell | 0.64883698 |
| 151 | MP0000003_abnormal_adipose_tissue | 0.63416680 |
| 152 | MP0002184_abnormal_innervation | 0.60664045 |
| 153 | MP0001440_abnormal_grooming_behavior | 0.58105030 |
| 154 | MP0001177_atelectasis | 0.57903593 |
| 155 | MP0000678_abnormal_parathyroid_gland | 0.57859961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.47660387 |
| 2 | Abnormality of the lower motor neuron (HP:0002366) | 3.80662503 |
| 3 | Xanthomatosis (HP:0000991) | 3.45235766 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.23191005 |
| 5 | Myokymia (HP:0002411) | 2.97324789 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.96438296 |
| 7 | Ulnar bowing (HP:0003031) | 2.94797245 |
| 8 | Abnormality of the Achilles tendon (HP:0005109) | 2.92486965 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 2.90890090 |
| 10 | Turricephaly (HP:0000262) | 2.85465251 |
| 11 | Shallow orbits (HP:0000586) | 2.81507106 |
| 12 | Lymphangioma (HP:0100764) | 2.78672747 |
| 13 | Complement deficiency (HP:0004431) | 2.76850243 |
| 14 | Abnormality of dentin (HP:0010299) | 2.74594565 |
| 15 | Neonatal short-limb short stature (HP:0008921) | 2.67471108 |
| 16 | Achilles tendon contracture (HP:0001771) | 2.62612737 |
| 17 | Protrusio acetabuli (HP:0003179) | 2.59611231 |
| 18 | Ketosis (HP:0001946) | 2.58179590 |
| 19 | Gout (HP:0001997) | 2.58172554 |
| 20 | Hepatoblastoma (HP:0002884) | 2.53516550 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 2.52616054 |
| 22 | Upper limb amyotrophy (HP:0009129) | 2.51402896 |
| 23 | Distal upper limb amyotrophy (HP:0007149) | 2.51402896 |
| 24 | Epidermoid cyst (HP:0200040) | 2.50483560 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.47231369 |
| 26 | Hyperacusis (HP:0010780) | 2.46793134 |
| 27 | Fragile skin (HP:0001030) | 2.45476412 |
| 28 | Bowel diverticulosis (HP:0005222) | 2.40568181 |
| 29 | Disproportionate tall stature (HP:0001519) | 2.39950871 |
| 30 | Insomnia (HP:0100785) | 2.37978409 |
| 31 | Ketoacidosis (HP:0001993) | 2.36356983 |
| 32 | Torticollis (HP:0000473) | 2.35256903 |
| 33 | Cerebral inclusion bodies (HP:0100314) | 2.32994620 |
| 34 | Biconcave vertebral bodies (HP:0004586) | 2.27750552 |
| 35 | Elfin facies (HP:0004428) | 2.26701310 |
| 36 | Long palpebral fissure (HP:0000637) | 2.26311213 |
| 37 | Renovascular hypertension (HP:0100817) | 2.26127147 |
| 38 | Spinal rigidity (HP:0003306) | 2.25766680 |
| 39 | Hand muscle atrophy (HP:0009130) | 2.25423075 |
| 40 | Mitral regurgitation (HP:0001653) | 2.25185192 |
| 41 | Arnold-Chiari malformation (HP:0002308) | 2.24931734 |
| 42 | Hypoalphalipoproteinemia (HP:0003233) | 2.24546261 |
| 43 | Neonatal onset (HP:0003623) | 2.24357023 |
| 44 | Vertebral compression fractures (HP:0002953) | 2.23259915 |
| 45 | Hyperammonemia (HP:0001987) | 2.23173484 |
| 46 | Hyperglycinuria (HP:0003108) | 2.21673419 |
| 47 | Cerebral aneurysm (HP:0004944) | 2.19559005 |
| 48 | Ankle contracture (HP:0006466) | 2.18638072 |
| 49 | Supranuclear gaze palsy (HP:0000605) | 2.18006234 |
| 50 | Atrophic scars (HP:0001075) | 2.15512005 |
| 51 | Skin nodule (HP:0200036) | 2.15398533 |
| 52 | Abnormality of complement system (HP:0005339) | 2.14550294 |
| 53 | Flat cornea (HP:0007720) | 2.13478257 |
| 54 | Abnormality of the aortic arch (HP:0012303) | 2.13099907 |
| 55 | Asymmetry of the thorax (HP:0001555) | 2.12575795 |
| 56 | Hypobetalipoproteinemia (HP:0003563) | 2.10717699 |
| 57 | Blue sclerae (HP:0000592) | 2.10013754 |
| 58 | Thin ribs (HP:0000883) | 2.09761682 |
| 59 | Hypoventilation (HP:0002791) | 2.09752863 |
| 60 | Back pain (HP:0003418) | 2.09694574 |
| 61 | Renal duplication (HP:0000075) | 2.09455185 |
| 62 | Coronal craniosynostosis (HP:0004440) | 2.08376135 |
| 63 | Focal dystonia (HP:0004373) | 2.06656068 |
| 64 | Broad metatarsal (HP:0001783) | 2.05478122 |
| 65 | Vascular tortuosity (HP:0004948) | 2.04140616 |
| 66 | Hyperextensible skin (HP:0000974) | 2.03996453 |
| 67 | Mitral valve prolapse (HP:0001634) | 2.03475036 |
| 68 | Pseudobulbar signs (HP:0002200) | 2.03233670 |
| 69 | Craniofacial dystonia (HP:0012179) | 2.02643188 |
| 70 | Patellar dislocation (HP:0002999) | 2.02365252 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.01760601 |
| 72 | Bronchomalacia (HP:0002780) | 2.01485651 |
| 73 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.00604088 |
| 74 | Abnormality of glycine metabolism (HP:0010895) | 2.00604088 |
| 75 | Wormian bones (HP:0002645) | 2.00040840 |
| 76 | Arterial tortuosity (HP:0005116) | 1.97566205 |
| 77 | Hypolipoproteinemia (HP:0010981) | 1.95965873 |
| 78 | Delayed CNS myelination (HP:0002188) | 1.95107854 |
| 79 | Increased nuchal translucency (HP:0010880) | 1.94593629 |
| 80 | Wide anterior fontanel (HP:0000260) | 1.94377572 |
| 81 | Soft skin (HP:0000977) | 1.94252851 |
| 82 | Obstructive sleep apnea (HP:0002870) | 1.94008506 |
| 83 | Peritonitis (HP:0002586) | 1.93641576 |
| 84 | Broad face (HP:0000283) | 1.92575072 |
| 85 | Hyperparathyroidism (HP:0000843) | 1.92554837 |
| 86 | Bladder diverticulum (HP:0000015) | 1.92492451 |
| 87 | Hypercalcemia (HP:0003072) | 1.92296368 |
| 88 | Spastic diplegia (HP:0001264) | 1.92107973 |
| 89 | Status epilepticus (HP:0002133) | 1.92033336 |
| 90 | Hyperglycinemia (HP:0002154) | 1.90221904 |
| 91 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.89576809 |
| 92 | Aplasia of the phalanges of the hand (HP:0009802) | 1.89576809 |
| 93 | Aplasia involving bones of the extremities (HP:0009825) | 1.89576809 |
| 94 | Action tremor (HP:0002345) | 1.89201178 |
| 95 | Cervical subluxation (HP:0003308) | 1.85661718 |
| 96 | Partial duplication of the phalanx of hand (HP:0009999) | 1.85421467 |
| 97 | Vertebral arch anomaly (HP:0008438) | 1.84885775 |
| 98 | Aortic dissection (HP:0002647) | 1.84821313 |
| 99 | Abnormality of the calcaneus (HP:0008364) | 1.84559263 |
| 100 | Visual hallucinations (HP:0002367) | 1.83073804 |
| 101 | Precocious puberty (HP:0000826) | 1.82940754 |
| 102 | Long toe (HP:0010511) | 1.81985079 |
| 103 | Abnormality of the diencephalon (HP:0010662) | 1.79652183 |
| 104 | Broad distal phalanx of finger (HP:0009836) | 1.78468901 |
| 105 | Nuclear cataract (HP:0100018) | 1.78283304 |
| 106 | Enlarged penis (HP:0000040) | 1.76969159 |
| 107 | Hypercholesterolemia (HP:0003124) | 1.76442972 |
| 108 | Cortical dysplasia (HP:0002539) | 1.74882821 |
| 109 | Megalocornea (HP:0000485) | 1.74815771 |
| 110 | Neoplasm of the heart (HP:0100544) | 1.74815636 |
| 111 | Abnormal cartilage morphology (HP:0002763) | 1.74573835 |
| 112 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.74179552 |
| 113 | Premature rupture of membranes (HP:0001788) | 1.73966748 |
| 114 | Partial duplication of thumb phalanx (HP:0009944) | 1.73585424 |
| 115 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.73088473 |
| 116 | Myocardial infarction (HP:0001658) | 1.73009345 |
| 117 | Visceral angiomatosis (HP:0100761) | 1.72950165 |
| 118 | Abnormal social behavior (HP:0012433) | 1.72546582 |
| 119 | Impaired social interactions (HP:0000735) | 1.72546582 |
| 120 | Polygenic inheritance (HP:0010982) | 1.71628468 |
| 121 | Congenital glaucoma (HP:0001087) | 1.70941926 |
| 122 | Trigonocephaly (HP:0000243) | 1.70637741 |
| 123 | Prolonged partial thromboplastin time (HP:0003645) | 1.69981224 |
| 124 | Macroorchidism (HP:0000053) | 1.68997389 |
| 125 | Overriding aorta (HP:0002623) | 1.67839724 |
| 126 | Malnutrition (HP:0004395) | 1.67797419 |
| 127 | Abnormality of the common coagulation pathway (HP:0010990) | 1.67299899 |
| 128 | Increased connective tissue (HP:0009025) | 1.67293951 |
| 129 | Increased variability in muscle fiber diameter (HP:0003557) | 1.66989906 |
| 130 | Joint laxity (HP:0001388) | 1.66213000 |
| 131 | Hallux valgus (HP:0001822) | 1.66039845 |
| 132 | Deviation of the hallux (HP:0010051) | 1.65988283 |
| 133 | Hepatocellular carcinoma (HP:0001402) | 1.65709594 |
| 134 | Midface retrusion (HP:0011800) | 1.65610852 |
| 135 | Broad thumb (HP:0011304) | 1.65447976 |
| 136 | Hamartoma of the eye (HP:0010568) | 1.65409616 |
| 137 | Bowed forearm bones (HP:0003956) | 1.65188752 |
| 138 | Bowing of the arm (HP:0006488) | 1.65188752 |
| 139 | Aneurysm (HP:0002617) | 1.64877389 |
| 140 | Hypercortisolism (HP:0001578) | 1.64857170 |
| 141 | Pointed chin (HP:0000307) | 1.64743742 |
| 142 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.64661647 |
| 143 | Megalencephaly (HP:0001355) | 1.63449484 |
| 144 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.63414826 |
| 145 | Hemiplegia (HP:0002301) | 1.62464821 |
| 146 | Thin bony cortex (HP:0002753) | 1.62400611 |
| 147 | Genu recurvatum (HP:0002816) | 1.62339963 |
| 148 | Amyotrophic lateral sclerosis (HP:0007354) | 1.62304727 |
| 149 | Difficulty running (HP:0009046) | 1.61954461 |
| 150 | Venous abnormality (HP:0002624) | 1.61949867 |
| 151 | Calcaneovalgus deformity (HP:0001848) | 1.61927275 |
| 152 | Lower limb amyotrophy (HP:0007210) | 1.61277046 |
| 153 | Morphological abnormality of the middle ear (HP:0008609) | 1.61013747 |
| 154 | Natal tooth (HP:0000695) | 1.60448824 |
| 155 | Hemangiomatosis (HP:0007461) | 1.59538532 |
| 156 | Mitral stenosis (HP:0001718) | 1.59245230 |
| 157 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.59131606 |
| 158 | Abnormality of purine metabolism (HP:0004352) | 1.58742330 |
| 159 | Annular pancreas (HP:0001734) | 1.58609959 |
| 160 | Broad long bones (HP:0005622) | 1.58499547 |
| 161 | Choanal stenosis (HP:0000452) | 1.58410988 |
| 162 | High anterior hairline (HP:0009890) | 1.58087053 |
| 163 | Hypoglycemic coma (HP:0001325) | 1.57868302 |
| 164 | Focal seizures (HP:0007359) | 1.57783333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.37474519 |
| 2 | PKN2 | 2.75126096 |
| 3 | MARK1 | 2.67255384 |
| 4 | SMG1 | 2.58294155 |
| 5 | ERN1 | 2.56630831 |
| 6 | MAP3K9 | 2.55069438 |
| 7 | RIPK1 | 2.34114362 |
| 8 | DAPK2 | 2.15852286 |
| 9 | SIK1 | 2.11734912 |
| 10 | LATS2 | 2.10842414 |
| 11 | EPHA4 | 2.02148105 |
| 12 | PAK6 | 1.99125550 |
| 13 | KSR2 | 1.92400623 |
| 14 | PRKD3 | 1.90743307 |
| 15 | TYRO3 | 1.89616000 |
| 16 | PDGFRA | 1.85603270 |
| 17 | ICK | 1.82328581 |
| 18 | CAMKK1 | 1.76995406 |
| 19 | PRPF4B | 1.73401932 |
| 20 | NTRK1 | 1.68464691 |
| 21 | SIK2 | 1.66226238 |
| 22 | DDR2 | 1.64372031 |
| 23 | EPHB2 | 1.62142980 |
| 24 | TAOK1 | 1.60309904 |
| 25 | MAP3K10 | 1.56206378 |
| 26 | PTK6 | 1.45331636 |
| 27 | MINK1 | 1.45052931 |
| 28 | NTRK3 | 1.37874934 |
| 29 | MAP2K4 | 1.31757464 |
| 30 | FGFR4 | 1.24497790 |
| 31 | EPHA2 | 1.24429635 |
| 32 | BMX | 1.22250395 |
| 33 | PTK2 | 1.18481910 |
| 34 | RET | 1.16369997 |
| 35 | NME2 | 1.16031018 |
| 36 | ARAF | 1.16000295 |
| 37 | NEK1 | 1.15881713 |
| 38 | STK38 | 1.10862472 |
| 39 | KSR1 | 1.10584377 |
| 40 | BCKDK | 1.08676774 |
| 41 | ALK | 1.07844548 |
| 42 | MAP3K2 | 1.07712722 |
| 43 | PHKG2 | 1.06494317 |
| 44 | PHKG1 | 1.06494317 |
| 45 | LIMK1 | 1.04779413 |
| 46 | IRAK3 | 1.01954195 |
| 47 | NTRK2 | 1.01417796 |
| 48 | MAP3K4 | 0.99676499 |
| 49 | CDK12 | 0.99057477 |
| 50 | CAMK1G | 0.98155160 |
| 51 | PAK3 | 0.96010906 |
| 52 | MARK2 | 0.92614274 |
| 53 | TAOK2 | 0.92406034 |
| 54 | BRAF | 0.91535950 |
| 55 | MAP3K7 | 0.90159340 |
| 56 | LMTK2 | 0.89946329 |
| 57 | ERBB2 | 0.87924677 |
| 58 | GRK5 | 0.85197560 |
| 59 | FER | 0.84014885 |
| 60 | PRKCH | 0.82183945 |
| 61 | CDK5 | 0.82146977 |
| 62 | LATS1 | 0.79757544 |
| 63 | TTN | 0.79116440 |
| 64 | PRKCZ | 0.79034102 |
| 65 | CAMK1D | 0.78232857 |
| 66 | RPS6KB2 | 0.76980813 |
| 67 | FGFR2 | 0.76025044 |
| 68 | BRSK1 | 0.75470209 |
| 69 | EEF2K | 0.75168165 |
| 70 | DYRK1B | 0.75033100 |
| 71 | DMPK | 0.74761006 |
| 72 | MTOR | 0.74737629 |
| 73 | MAP2K1 | 0.74704251 |
| 74 | MOS | 0.72259671 |
| 75 | CAMK4 | 0.71495076 |
| 76 | STK11 | 0.70286083 |
| 77 | CDK7 | 0.69808286 |
| 78 | NEK2 | 0.68955230 |
| 79 | ROCK2 | 0.67600588 |
| 80 | DAPK1 | 0.64119142 |
| 81 | PAK2 | 0.63365545 |
| 82 | DAPK3 | 0.60525017 |
| 83 | MET | 0.59821254 |
| 84 | UHMK1 | 0.59649277 |
| 85 | CDK15 | 0.58109247 |
| 86 | RPS6KC1 | 0.57694560 |
| 87 | RPS6KL1 | 0.57694560 |
| 88 | CDC42BPA | 0.57376723 |
| 89 | PAK4 | 0.56613764 |
| 90 | DYRK2 | 0.56168113 |
| 91 | PDPK1 | 0.55853207 |
| 92 | RPS6KA2 | 0.54417411 |
| 93 | CDK14 | 0.54079152 |
| 94 | PRKCG | 0.53996836 |
| 95 | ILK | 0.53788498 |
| 96 | PDGFRB | 0.53735763 |
| 97 | PRKD1 | 0.53201204 |
| 98 | CDK18 | 0.53151310 |
| 99 | AKT2 | 0.51933343 |
| 100 | VRK2 | 0.51076709 |
| 101 | BRD4 | 0.51005486 |
| 102 | MAPK12 | 0.49842049 |
| 103 | CDK11A | 0.49517740 |
| 104 | FGFR1 | 0.47901199 |
| 105 | MAP2K2 | 0.47843590 |
| 106 | TESK2 | 0.47411781 |
| 107 | MAP3K1 | 0.47197779 |
| 108 | PTK2B | 0.46587277 |
| 109 | PRKD2 | 0.46344205 |
| 110 | SGK3 | 0.44961719 |
| 111 | PRKAA1 | 0.44729256 |
| 112 | LRRK2 | 0.43792124 |
| 113 | HIPK2 | 0.43586202 |
| 114 | MAP3K8 | 0.43581461 |
| 115 | ROCK1 | 0.42393073 |
| 116 | ERBB4 | 0.42083489 |
| 117 | AURKA | 0.41981074 |
| 118 | MAPK10 | 0.41403722 |
| 119 | GSK3A | 0.41047412 |
| 120 | CDK6 | 0.41043311 |
| 121 | PRKG2 | 0.40784762 |
| 122 | MST1R | 0.40436485 |
| 123 | TGFBR2 | 0.40236005 |
| 124 | PNCK | 0.40131443 |
| 125 | CAMK2G | 0.39964051 |
| 126 | MATK | 0.39773975 |
| 127 | TESK1 | 0.39397792 |
| 128 | WNK4 | 0.38463112 |
| 129 | SCYL2 | 0.38075114 |
| 130 | CDK9 | 0.37845565 |
| 131 | CAMK2B | 0.37700232 |
| 132 | PDK1 | 0.37696829 |
| 133 | ABL2 | 0.37674616 |
| 134 | GRK6 | 0.37579211 |
| 135 | MAPKAPK3 | 0.37339170 |
| 136 | MAP3K11 | 0.37186216 |
| 137 | RPS6KA6 | 0.35664835 |
| 138 | CSNK1E | 0.34291689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.63555364 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96594484 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.78290410 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.46455061 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.20878627 |
| 6 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.92891645 |
| 7 | Bile secretion_Homo sapiens_hsa04976 | 1.81460256 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77590811 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.75997814 |
| 10 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.73415227 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.73075111 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.71391157 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.70911485 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.66661813 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.65948466 |
| 16 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.61605510 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.55683329 |
| 18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.52824114 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.52437042 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.46636967 |
| 21 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.46396262 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.41140337 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40022814 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.39301386 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.36090565 |
| 26 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.35023616 |
| 27 | Adherens junction_Homo sapiens_hsa04520 | 1.30693495 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30660914 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.25340123 |
| 30 | Thyroid cancer_Homo sapiens_hsa05216 | 1.18913584 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.16919268 |
| 32 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.16308040 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14305205 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.13733541 |
| 35 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.09778990 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09177666 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08290468 |
| 38 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.07045358 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.06164158 |
| 40 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.05952102 |
| 41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.05165161 |
| 42 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.03863785 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03587898 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02082871 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.02017730 |
| 46 | Tight junction_Homo sapiens_hsa04530 | 0.95899269 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93765238 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.93478349 |
| 49 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.92707302 |
| 50 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.90850418 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90320307 |
| 52 | GABAergic synapse_Homo sapiens_hsa04727 | 0.89209373 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87816709 |
| 54 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87595415 |
| 55 | Glioma_Homo sapiens_hsa05214 | 0.87291774 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.87158342 |
| 57 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.86510570 |
| 58 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84903388 |
| 59 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.83072478 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82912245 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.81757376 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.81057556 |
| 63 | Melanoma_Homo sapiens_hsa05218 | 0.80636760 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.80629309 |
| 65 | Prostate cancer_Homo sapiens_hsa05215 | 0.79948207 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.79668990 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79112289 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78630679 |
| 69 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78023794 |
| 70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.77249031 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77031159 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76297021 |
| 73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75908646 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75604446 |
| 75 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.75113087 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74412940 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74246993 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73327443 |
| 79 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.73312334 |
| 80 | Olfactory transduction_Homo sapiens_hsa04740 | 0.73108063 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72727455 |
| 82 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72488721 |
| 83 | Axon guidance_Homo sapiens_hsa04360 | 0.72422585 |
| 84 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72159706 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.71104036 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70937100 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.70063327 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69420426 |
| 89 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69418400 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69050294 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69014638 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68535715 |
| 93 | Gap junction_Homo sapiens_hsa04540 | 0.67983805 |
| 94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67634409 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.67026936 |
| 96 | Salivary secretion_Homo sapiens_hsa04970 | 0.66830003 |
| 97 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66427688 |
| 98 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66406492 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65861990 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64507547 |
| 101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64201564 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64194546 |
| 103 | Cocaine addiction_Homo sapiens_hsa05030 | 0.63940131 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63931466 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63843837 |
| 106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63091752 |
| 107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.61892551 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61099600 |
| 109 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60935964 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60913739 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60611259 |
| 112 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60410473 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60352466 |
| 114 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57544272 |
| 115 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57362395 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57241764 |
| 117 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56949229 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56944049 |
| 119 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.56758449 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56714597 |
| 121 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56524966 |
| 122 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56197006 |
| 123 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55774269 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.55268229 |
| 125 | Melanogenesis_Homo sapiens_hsa04916 | 0.54787163 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54656794 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54285974 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.53429213 |
| 129 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52321120 |
| 130 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51647566 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51545689 |
| 132 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51012729 |
| 133 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50731487 |
| 134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50285459 |
| 135 | Retinol metabolism_Homo sapiens_hsa00830 | 0.49959962 |
| 136 | Focal adhesion_Homo sapiens_hsa04510 | 0.48662281 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | 0.48045191 |
| 138 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48041915 |
| 139 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47016853 |
| 140 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46888296 |
| 141 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46585697 |
| 142 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.45731178 |
| 143 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45730786 |

